Related Experiment Video

Updated: Oct 13, 2026

Real-Time Void Spot Assay
06:39

Real-Time Void Spot Assay

Published on: February 10, 2023

Urinary excretion of deoxypyridinoline in 24-hour and first-void samples in healthy Turkish children

H Soylu1, S Aras, N O Kutlu

  • 1Department of Pediatrics, Inönü University, Turgut Ozal Medical Center, Malatya, Turkey. hasoylu@hotmail.com

Clinical Biochemistry
|August 11, 2000
PubMed

Insights

Urinary free deoxypyridinoline (f-Dpd) is a marker for bone disorders. Measuring f-Dpd in first-void urine is a simple and reliable method for children, avoiding lengthy collections.

Area of Science:

  • Biochemistry
  • Pediatric Endocrinology
  • Bone Metabolism

Background:

  • Collagen cross-links, like free deoxypyridinoline (f-Dpd), are crucial for bone matrix maturation.
  • f-Dpd is a potential biomarker for various bone disorders and can be measured in urine.
  • Excretion characteristics of f-Dpd in pediatric populations require further clarification.

Purpose of the Study:

  • To investigate urinary f-Dpd excretion in healthy Turkish children using first-void and 24-hour urine samples.
  • To evaluate correlations and gender-related differences in f-Dpd excretion between these two sampling methods.
  • To determine the feasibility of using first-void urine samples for f-Dpd assessment in pediatric populations.

Main Methods:

  • Analyzed urinary f-Dpd in first-void and 24-hour samples from 62 healthy children (31-120 months).
  • Utilized the Immulite chemiluminescent technique for sample analysis.
  • Assessed correlations and gender differences in f-Dpd excretion relative to creatinine.

Main Results:

  • No significant differences in f-Dpd excretion were observed between first-void and 24-hour urine samples.
  • A strong positive linear correlation (r=0.77, p<0.05) was found between the two collection methods.
  • f-Dpd excretion showed no gender-related differences in either sampling method (p>0.05).

Conclusions:

  • First-void urine samples provide a reliable and convenient method for assessing f-Dpd in children.
  • This non-invasive approach simplifies bone metabolism monitoring in infants and young children.
  • f-Dpd assessment in single voided urine samples is practical for pediatric clinical settings.
Abstract

Related Concept Videos

Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...